Back

Maximal functional capacity response to physical therapies according to ferrokinetics in heart failure with preserved ejection fraction. A substudy of the training-hf trial

21 May 2023 (11:00 - 11:35)
Organised by: Logo
Congress Presentation Part of: Heart failure with preserved ejection fraction (HFpEF) 3 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Patricia Palau Sampio

Valencia University Clinical Hospital, Valencia (Spain)

4 More presentations in this session

Presentation thumbnail
A ventricular conduction delay phenotype and its outcome in heart failure with preserved ejection fraction
Ms A. Achten (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Invasive validation of H2FPEF score for diagnosis of heart failure with preserved ejection fraction (HFpEF)
Doctor M. Podolec (Prague, CZ)
Abstract Slides
Presentation thumbnail
Retinal neurovascular changes in heart failure with preserved ejection fraction: an optical coherence tomography angiography pilot study
Mr J. Weerts (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Dapagliflozin and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
Doctor J. Ostrominski (Boston, US)
Abstract Slides

Access the full session

Session thumbnail
Heart failure with preserved ejection fraction (HFpEF) 3

The Event

Event poster

Heart Failure 2023

21 May 2023 11:00 CET
You may be interested in
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources